{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:54:59Z","timestamp":1782305699555,"version":"3.54.5"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[1998]]},"DOI":"10.1080\/00313029800169606","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T22:34:06Z","timestamp":1128638046000},"page":"335-347","source":"Crossref","is-referenced-by-count":50,"title":["Gene transfer: A review of methods and applications"],"prefix":"10.1016","volume":"30","author":[{"given":"H. Miles","family":"Prince","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/00313029800169606_bib0005","series-title":"NIH Proceedings-Dec 95 Report and recommendations of the panel to assess the NIH investment in research on gene therapy","author":"Orkin","year":"1995"},{"key":"10.1080\/00313029800169606_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.8211180","article-title":"Germ-line gene modification and disease prevention: some medical and ethical perspectives","volume":"262","author":"Wivel","year":"1993","journal-title":"Science"},{"key":"10.1080\/00313029800169606_bib0015","series-title":"Biology","author":"Raven","year":"1989"},{"key":"10.1080\/00313029800169606_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.79.2.137","article-title":"Studies on the chemical nature of the substance inducing transformation of pneumococcal types","volume":"79","author":"Avery","year":"1944","journal-title":"J Exp Med"},{"key":"10.1080\/00313029800169606_bib0025","series-title":"Molecular Biology of the Gene","author":"Watson","year":"1988"},{"key":"10.1080\/00313029800169606_bib0030","series-title":"The Retroviradae","author":"Temin","year":"1992"},{"key":"10.1080\/00313029800169606_bib0035","series-title":"Virology","author":"Coffin","year":"1990"},{"key":"10.1080\/00313029800169606_bib0040","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1073\/pnas.91.15.7071","article-title":"Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters","volume":"91","author":"Kavanangh","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0045","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1073\/pnas.91.3.1168","article-title":"A human amphotrophic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family","volume":"91","author":"Van Zeul","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0050","series-title":"Mol Cell Biol","first-page":"4239","article-title":"Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection","author":"Miller","year":"1990"},{"key":"10.1080\/00313029800169606_bib0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1089\/hum.1996.7.8-913","article-title":"Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors","volume":"7","author":"Porter","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0060","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1073\/pnas.83.23.9211","article-title":"Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses","volume":"83","author":"Gelinas","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0065","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.176.4.1125","article-title":"Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer","volume":"176","author":"Donahue","year":"1992","journal-title":"J Exp Med"},{"key":"10.1080\/00313029800169606_bib0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0958-1669(94)90084-1","article-title":"Gene therapy using adenoviral vectors","volume":"5","author":"Trapnell","year":"1994","journal-title":"Curt Opin Biotechnol"},{"key":"10.1080\/00313029800169606_bib0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.bmb.a072951","article-title":"Adenovirus and adeno-associated virus mediated gene transfer","volume":"51","author":"Kremer","year":"1995","journal-title":"Br Med Bull"},{"key":"10.1080\/00313029800169606_bib0080","series-title":"The Adenoviruses","author":"Ginsberg","year":"1984"},{"key":"10.1080\/00313029800169606_bib0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0042-6822(92)90082-Z","article-title":"The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2","volume":"186","author":"Chroboczek","year":"1992","journal-title":"Virology"},{"key":"10.1080\/00313029800169606_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5.","volume":"36","author":"Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"10.1080\/00313029800169606_bib0095","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1128\/JVI.67.10.5911-5921.1993","article-title":"Packaging capacity and stability of human adenovirus type 5 vectors","volume":"67","author":"Bert","year":"1993","journal-title":"J Virol"},{"key":"10.1080\/00313029800169606_bib0100","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1073\/pnas.91.19.8802","article-title":"An efficient and flexible system for construction of adenovirus vectors with insertions and deletions in early regions 1 and 3","volume":"91","author":"Bett","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0105","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","article-title":"A helper-dependent adenovirus vector system: removal of the helper virus by Cre-mediated excision of the viral packaging signal","volume":"93","author":"Parks","year":"1996","journal-title":"Proc ?Cad Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0110","series-title":"Cancer Gene Ther","first-page":"321","article-title":"Strategies to accomplish targeted gene delivery implying tropism-modified recombinant adenovirat vectors","author":"Michael","year":"1995"},{"key":"10.1080\/00313029800169606_bib0115","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1128\/JVI.71.10.7663-7669.1997","article-title":"Targeted adenovirus-mediated gene delivery to T cells via CD3","volume":"71","author":"Wickham","year":"1997","journal-title":"J Virol"},{"key":"10.1080\/00313029800169606_bib0120","first-page":"750","article-title":"Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs","volume":"2","author":"Wickham","year":"1995","journal-title":"Gene Ther"},{"key":"10.1080\/00313029800169606_bib0125","first-page":"262","article-title":"A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy","volume":"3","author":"Neve","year":"1996","journal-title":"Clin Neurosci"},{"key":"10.1080\/00313029800169606_bib0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/13550289709015801","article-title":"The roles of herpes simplex virus in neuroscience","volume":"3","author":"Turner","year":"1997","journal-title":"J Neurovirol"},{"key":"10.1080\/00313029800169606_bib0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02824809","article-title":"Herpes simplex virus vector for gene therapy","volume":"2","author":"Latchman","year":"1994","journal-title":"Mol Biotechnol"},{"key":"10.1080\/00313029800169606_bib0140","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1073\/pnas.83.10.3496","article-title":"Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field mediated DNA transfer","volume":"83","author":"Toneguzzo","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0145","first-page":"485","article-title":"Engraftment of donor-derived bone marrow stromal cells","volume":"19","author":"Wu","year":"1991","journal-title":"Exp Hematol"},{"key":"10.1080\/00313029800169606_bib0150","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.84.23.8463","article-title":"Transfection of mammalian cells with plasmid DNA by scrape loading and sonicating loading","volume":"84","author":"Fechheimer","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0155","first-page":"667","article-title":"Glass beads load macromolecules into living cells","volume":"88","author":"MacNeil","year":"1987","journal-title":"J Cell Sci"},{"key":"10.1080\/00313029800169606_bib0160","first-page":"697","article-title":"Bead transfection: rapid and efficient gene transfer into marrow stromal and other adherent mammalian cells","volume":"21","author":"Mathews","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1080\/00313029800169606_bib0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0955-3886(95)00055-0","article-title":"Gene therapy with physical methods of gene transfer","volume":"17","author":"Mathews","year":"1996","journal-title":"Transfusion Sci"},{"key":"10.1080\/00313029800169606_bib0170","first-page":"210","article-title":"The biology of hematopoietic stem cells","volume":"22","author":"Ratajczak","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1080\/00313029800169606_bib0175","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V81.11.2844.2844","article-title":"Differentiation and proliferation of hematopoietic stem cells","volume":"81","author":"Ogawa","year":"1993","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0180","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood.V84.12.3991.bloodjournal84123991","article-title":"What defines a pluripotent hematopoietic stem cell (PHSC): will the real PHSC please stand up!","volume":"84","author":"Orlic","year":"1994","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0185","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1089\/hum.1993.4.2-129","article-title":"Targeting retroviral vectors for gene therapy","volume":"4","author":"Salmons","year":"1993","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0190","doi-asserted-by":"crossref","first-page":"35664","DOI":"10.1182\/blood.V79.2.356.356","article-title":"Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors","volume":"79","author":"Carter","year":"1992","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/hum.1996.7.1-33","article-title":"Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions","volume":"7","author":"Sekhar","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/hum.1996.7.2-207","article-title":"Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence","volume":"7","author":"Hatzfeld","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0205","first-page":"2089","article-title":"Prcclinical assessment of human hematopoietic cell transduction in long-term marrow cultures","volume":"7","author":"Dnbe","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0210","first-page":"148","article-title":"In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures","volume":"4","author":"Stewart","year":"1997","journal-title":"Cancer Gene Ther"},{"key":"10.1080\/00313029800169606_bib0215","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1089\/hum.1994.5.8-941","article-title":"Transduction of human bone marrow by adenoviral vector","volume":"5","author":"Mitani","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0220","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V88.4.1147.bloodjournal8841147","article-title":"Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors","volume":"88","author":"Neering","year":"1996","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0225","first-page":"27","article-title":"Adenoviral mediated B7 gene transduction of malignant human plasma cells","volume":"26","author":"Prince","year":"1998","journal-title":"Exp Hematol"},{"key":"10.1080\/00313029800169606_bib0230","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/hum.1992.3.6-619","article-title":"Simultaneous use of two retroviral vectors in human gene marking trials: feasibility and potential applications","volume":"3","author":"Miller","year":"1992","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0235","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.V78.3.624.624","article-title":"Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays","volume":"78","author":"Dick","year":"1991","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0240","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0140-6736(93)92122-A","article-title":"Gene marking to determine whether autologous marrow infusion restores long-term haematopoiesis in cancer patients","volume":"342","author":"Brenner","year":"1993","journal-title":"Lancet"},{"key":"10.1080\/00313029800169606_bib0245","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/scd.1.1996.5.553","article-title":"Gene marking and gene therapy for transplantation medicine","volume":"5","author":"Dilloo","year":"1996","journal-title":"J Hematother"},{"key":"10.1080\/00313029800169606_bib0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","article-title":"Gene marking to trace origin of relapse after autologous bone marrow transplantation for acute myelogenous leukemia","volume":"341","author":"Brenner","year":"1993","journal-title":"Lancet"},{"key":"10.1080\/00313029800169606_bib0255","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood.V83.10.3068.3068","article-title":"Genetic marking show that Fh + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML","volume":"83","author":"Deisseroth","year":"1994","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1994.tb21713.x","article-title":"Gene marking and autologous bone marrow transplant","volume":"1","author":"Brenner","year":"1994","journal-title":"Annals New York Academy of Sciences"},{"key":"10.1080\/00313029800169606_bib0265","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJM199008303230904","article-title":"Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphoeytes modified by retroviral gene transducfion","volume":"323","author":"Rosenberg","year":"1990","journal-title":"New Engl Med"},{"key":"10.1080\/00313029800169606_bib0270","first-page":"118","article-title":"Tumour-infiltrating lymphocytes in gene therapy","volume":"45","author":"Platsoucas","year":"1993","journal-title":"Cancer Bull"},{"key":"10.1080\/00313029800169606_bib0275","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1200\/JCO.1995.13.2.410","article-title":"Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes trmasduced with the gene of resistance to neomycin","volume":"13","author":"Merrouche","year":"1995","journal-title":"J CIin Oncol"},{"key":"10.1080\/00313029800169606_bib0280","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V85.11.3048.bloodjournal85113048","article-title":"Retrovirally marked CD34-enfiched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation","volume":"85","author":"Dunbar","year":"1995","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0955-3886(95)00071-2","article-title":"Background and update to a Phase I trial of stem celt gene marking in multiple myeloma","volume":"17","author":"Stewart","year":"1995","journal-title":"Transfusion Sci"},{"issue":"Suppl 1","key":"10.1080\/00313029800169606_bib0290","first-page":"172a","article-title":"Gene therapy strategies for the treatment of multiple myeloma","volume":"84","author":"Munshi","year":"1994","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0295","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1073\/pnas.94.22.12133","article-title":"Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease","volume":"94","author":"Malech","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0300","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA(-) SCID: Initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1080\/00313029800169606_bib0305","first-page":"46","article-title":"Transfer of drug resistance benes into hematopoietic progenitors to improve chemotherapy tolerance","volume":"23","author":"Koc","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1080\/00313029800169606_bib0310","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/jnci\/82.15.1234","article-title":"\u2018Turning the tahles\u2019--normal marrow resistant to chemotherapy","volume":"82","author":"Bertino","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1080\/00313029800169606_bib0315","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0038-1646379","article-title":"Status of gene transfer for haemophilia A and B","volume":"66","author":"Thompson","year":"1991","journal-title":"Thrombosis Haemostasis"},{"key":"10.1080\/00313029800169606_bib0320","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/oxfordjournals.bmb.a072956","article-title":"Prospects for gene therapy of haemophitia A and B","volume":"51","author":"Brownlee","year":"1995","journal-title":"Br Med Bull"},{"key":"10.1080\/00313029800169606_bib0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0038-1657496","article-title":"Gene therapy for hemophilia A","volume":"78","author":"Connelly","year":"1997","journal-title":"Thrombosis Haemostasis"},{"key":"10.1080\/00313029800169606_bib0330","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/hum.1994.5.8-927","article-title":"Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention","volume":"5","author":"Dropulic","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0335","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1001\/jama.1993.03500220066028","article-title":"Molecular targets of gene transfer therapy for HIV infection","volume":"269","author":"Buchschacher","year":"1993","journal-title":"J Am Med Assoc"},{"key":"10.1080\/00313029800169606_bib0340","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/oxfordjournals.bmb.a072944","article-title":"Gene therapy for HIV infection","volume":"51","author":"Lever","year":"1995","journal-title":"Br Med Bull"},{"key":"10.1080\/00313029800169606_bib0345","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/hum.1994.5.5-595","article-title":"Intracellular antibodies as a new class of therapeutic molecules for gene therapy","volume":"5","author":"Chert","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0350","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1089\/hum.1995.6.10-1259","article-title":"The impact of gene therapy on T cell function in cancer","volume":"6","author":"Zier","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0355","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00001622-199212000-00018","article-title":"Immunotherapy with cytokine gene-transduced tumor ceils: the next wave in gene therapy for cancer","volume":"4","author":"Pardoll","year":"1992","journal-title":"Curr Opin Oncol"},{"key":"10.1080\/00313029800169606_bib0360","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.iy.10.040192.003153","article-title":"Tumor antigens","volume":"10","author":"Urban","year":"1992","journal-title":"Annu Re*, hnmunol"},{"key":"10.1080\/00313029800169606_bib0365","series-title":"Important Advances in Oncology.","author":"Boon","year":"1994"},{"key":"10.1080\/00313029800169606_bib0370","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1080\/00313029800169606_bib0375","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0167-5699(93)90262-J","article-title":"Costimulation of T cells for tumor immunity","volume":"14","author":"Chen","year":"1993","journal-title":"Immunol Today"},{"key":"10.1080\/00313029800169606_bib0380","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1146\/annurev.iy.10.040192.003241","article-title":"The T cell receptor as a multicomponent signalling machine: CD4\/CD8 coreceptors and CD45 in T cell activation","volume":"10","author":"Janeway","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1080\/00313029800169606_bib0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-065X.1987.tb00502.x","article-title":"T cell responsiveness in vivo and in vitro fine specificity of induction and molecular characterization of the unresponsive state","volume":"95","author":"Jenkins","year":"1987","journal-title":"Immunol Rev"},{"key":"10.1080\/00313029800169606_bib0390","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/hum.1995.6.10-1299","article-title":"B7-1 amplifies the response to interteukin-2-secreting tumor vaccines in vivo, but fails to induce a response by naive cells in vitro.","volume":"6","author":"Salvadori","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0395","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hum.1994.5.2-153","article-title":"Experimental and clinical studies of cytokine gene-modified tumor cells","volume":"5","author":"Tepper","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0400","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s002620050349","article-title":"A case report: immune responses and clinical course of the first human use of granulocyte\/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy","volume":"44","author":"Ellem","year":"1997","journal-title":"Cancer Immunot Immunother"},{"key":"10.1080\/00313029800169606_bib0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/hum.1997.8.1-111","article-title":"A phase I study of vaccination with autologous, irradiated melanoma cell engineered to secrete human granulocyte-macrophage colony stimulating factor","volume":"8","author":"Dranoff","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0410","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V84.10.3261.3261","article-title":"Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity","volume":"84","author":"Guinan","year":"1994","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0415","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0092-8674(05)80059-5","article-title":"Costimulation of antitumor immunity by the B7 counter-receptor for the T Iymphocyte molecules CD28 and CTLA-4","volume":"71","author":"Chen","year":"1992","journal-title":"Cell"},{"key":"10.1080\/00313029800169606_bib0420","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1073\/pnas.90.12.5687","article-title":"Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules","volume":"90","author":"Basker","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0425","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood.V85.9.2507.bloodjournal8592507","article-title":"Role of B7-1 in mediating an immune response to myeloid leukemia cells","volume":"85","author":"Matulonis","year":"1995","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0430","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1084\/jem.179.2.523","article-title":"Tumor immunogenicity determines the effects of B7 costimulation on T cell-mediated tumor immunity","volume":"179","author":"Chen","year":"1994","journal-title":"J Exp Med"},{"key":"10.1080\/00313029800169606_bib0435","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/eji.1830250831","article-title":"Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines","volume":"25","author":"Cayeux","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1080\/00313029800169606_bib0440","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.1993.tb44011.x","article-title":"On the role of costimulation in tumor immunity","volume":"690","author":"Hellstrom","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1080\/00313029800169606_bib0445","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.94.20.10889","article-title":"Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression","volume":"94","author":"Putzer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/00313029800169606_bib0450","series-title":"Gene Ther Meet Cold Spring Harbor","first-page":"69","article-title":"Improvement of murine gene therapy using IL-t2 by tumour cell stably expressing costimulatory molecules of the TNF family","author":"Ciuderc","year":"1996"},{"key":"10.1080\/00313029800169606_bib0455","first-page":"317","article-title":"Tumor cells transfected with B7-1 + IL 12 cDNA induce lasting protective immunity","volume":"2","author":"Ksander","year":"1995","journal-title":"Cancer Gene Ther"},{"key":"10.1080\/00313029800169606_bib0460","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/hum.1996.7.4-525","article-title":"Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant","volume":"7","author":"Cayeux","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1080\/00313029800169606_bib0465","first-page":"75","article-title":"Irradiation of singly and doubly transduced murine neuroblastoma cells expressing B7-1 and producing inter-feron-gamma reduces their capacity to induce systemic immunity","volume":"3","author":"Katsanis","year":"1996","journal-title":"Cancer Gene Ther"},{"key":"10.1080\/00313029800169606_bib0470","first-page":"192","article-title":"Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer","volume":"3","author":"Albertini","year":"1996","journal-title":"Cancer Gene Ther"},{"key":"10.1080\/00313029800169606_bib0475","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm0996-985","article-title":"Retrovims-mediated wild-type p53 gene transfer to tumors of patients with lung cancer","volume":"2","author":"Roth","year":"1996","journal-title":"Nat Med"},{"key":"10.1080\/00313029800169606_bib0480","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.V88.6.2192.bloodjournal8862192","article-title":"Suicide gene therapy for plasma cell tumours","volume":"88","author":"Dilber","year":"1996","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0485","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1317968","article-title":"In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain turnouts","volume":"256","author":"Culver","year":"1992","journal-title":"Science"},{"key":"10.1080\/00313029800169606_bib0490","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/nm1297-1354","article-title":"Therapy of malignant brain tumors by intramural implantation of retroviral vector-producing cells","volume":"3","author":"Ram","year":"1997","journal-title":"Nat Med"},{"key":"10.1080\/00313029800169606_bib0495","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1001\/jama.1993.03500180104043","article-title":"Multiple myeloma: new approaches to therapy","volume":"269","author":"Dunbar","year":"1993","journal-title":"J Am Med Assoc"},{"key":"10.1080\/00313029800169606_bib0500","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1182\/blood.V87.11.4510.bloodjournal87114510","article-title":"Human Interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells","volume":"87","author":"Sporeno","year":"1996","journal-title":"Blood"},{"key":"10.1080\/00313029800169606_bib0505","series-title":"Gene Ther Meet Cold Spring Harbor","first-page":"270","article-title":"Aden-ovirus mediated gene transfer of an IL6 antagonist","author":"Saggio","year":"1996"},{"key":"10.1080\/00313029800169606_bib0510","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V85.4.863.bloodjournal854863","article-title":"Interleukin-6 in human multiple myeloma","volume":"85","author":"Klein","year":"1995","journal-title":"Blood"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516348553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516348553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:48:27Z","timestamp":1586497707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516348553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998]]}},"alternative-id":["S0031302516348553"],"URL":"https:\/\/doi.org\/10.1080\/00313029800169606","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}